Edition:
India

Chromadex Corp (CDXC.OQ)

CDXC.OQ on NASDAQ Stock Exchange Capital Market

3.83USD
2:29am IST
Change (% chg)

$0.09 (+2.27%)
Prev Close
$3.74
Open
$3.79
Day's High
$3.91
Day's Low
$3.77
Volume
375,302
Avg. Vol
69,184
52-wk High
$4.95
52-wk Low
$2.68

Latest Key Developments (Source: Significant Developments)

Chromadex Q2 Loss Per Share $0.14
Thursday, 8 Aug 2019 

Aug 7 (Reuters) - Chromadex Corp ::ORATION REPORTS SECOND QUARTER 2019 FINANCIAL RESULTS.Q2 LOSS PER SHARE $0.14.Q2 SALES $11.1 MILLION VERSUS REFINITIV IBES ESTIMATE OF $10.8 MILLION.Q2 EARNINGS PER SHARE ESTIMATE $-0.13 -- REFINITIV IBES DATA.  Full Article

Pioneer Step Holdings Limited Reports 9.6 Percent Stake In Chromadex As Of May 9
Monday, 13 May 2019 

May 13 (Reuters) - Pioneer Step Holdings Ltd::PIONEER STEP HOLDINGS LIMITED REPORTS 9.6 PERCENT STAKE IN CHROMADEX CORP AS OF MAY 9, 2019 - SEC FILING.PIONEER STEP HOLDINGS LIMITED - HAD PREVIOUSLY REPORTED 8.1 PERCENT STAKE IN CHROMADEX CORP AS OF NOV 17, 2017.  Full Article

Chromadex Corporation Reports 2018 Financial Results
Friday, 8 Mar 2019 

March 7 (Reuters) - Chromadex Corp ::ORATION REPORTS 2018 FINANCIAL RESULTS.Q4 LOSS PER SHARE $0.15.Q4 SALES $9.1 MILLION VERSUS REFINITIV IBES ESTIMATE OF $9.1 MILLION.Q4 EARNINGS PER SHARE ESTIMATE $-0.14 -- REFINITIV IBES DATA.CONTINUE TO EXPECT COMPANY TO BE CASH FLOW BREAKEVEN BY Q4 OF 2019 OR EARLY 2020.  Full Article

Chromadex And Nestlé Health Science Sign Global Commercial License And Supply Deal
Friday, 21 Dec 2018 

Dec 20 (Reuters) - Chromadex Corp ::CHROMADEX CORP. AND NESTLÉ HEALTH SCIENCE ENTER GLOBAL COMMERCIAL LICENSE AND SUPPLY AGREEMENT FOR TRU NIAGEN®.CHROMADEX - AGREEMENT PROVIDES NHSC EXCLUSIVE RIGHT TO INCLUDE CO'S PATENTED NICOTINAMIDE RIBOSIDE INGREDIENT TRU NIAGEN IN NHSC BRANDED MEDICAL NUTRITION.CHROMADEX CORP - AGREEMENT PROVIDES NHSC CO-EXCLUSIVE RIGHTS TO INCLUDE TRU NIAGEN IN CERTAIN PRODUCTS WITHIN CONSUMER HEALTH CATEGORY.CHROMADEX CORP - UNDER TERMS OF AGREEMENT, NHSC WILL MAKE AN UPFRONT PAYMENT OF $4 MILLION.CHROMADEX - UNDER AGREEMENT CO WILL RECEIVE CERTAIN COMMERCIAL MILESTONE PAYMENTS RELATED TO SALE OF TRU NIAGEN® TO NHSC AS WELL AS TIERED ROYALTIES.  Full Article

Chromadex Says Tru Niagen Daily Serving Strengthened Under FDA NDI Notification
Wednesday, 24 Oct 2018 

Oct 24 (Reuters) - Chromadex Corp ::TRU NIAGEN® DAILY SERVING STRENGTHENED UNDER FDA’S NDI NOTIFICATION.CHROMADEX - STRENGTHENED FLAGSHIP TRU NIAGEN (NICOTINAMIDE RIBOSIDE) NUTRIENT TO 150MG CAPSULES, TWO PER DAY.  Full Article

Chromadex Corp Appoints Rob Fried as Chief Executive Officer
Tuesday, 24 Apr 2018 

April 23 (Reuters) - Chromadex Corp ::CHROMADEX APPOINTS FRANK JAKSCH AS EXECUTIVE CHAIRMAN, ROB FRIED AS CHIEF EXECUTIVE OFFICER AND KURT GUSTAFSON AS LEAD DIRECTOR.CHROMADEX CORP - JAKSCH SUCCEEDS STEPHEN ALLEN.CHROMADEX CORP - FRIED WILL SUCCEED FRANK JAKSCH AS CEO.  Full Article